We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$54.9B
AUM Growth
-$1.43B
Cap. Flow
-$10.1B
Cap. Flow %
-18.32%
Top 10 Hldgs %
15.84%
Holding
4,613
New
106
Increased
2,539
Reduced
1,420
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Financials 5.47%
3 Healthcare 4.96%
4 Consumer Discretionary 4.64%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENIA
3926
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$16.5K ﹤0.01%
1,500
-32,289
-96% -$320K
CTSO icon
3927
Cytosorbents Corp
CTSO
$23.3M
$16.4K ﹤0.01%
4,266
-550
-11% -$2.4K
AVTX icon
3928
Avalo Therapeutics
AVTX
$1.05B
$16.2K ﹤0.01%
+1
New +$10.5K
MBIO icon
3929
Mustang Bio
MBIO
$4.59M
$16.1K ﹤0.01%
5
+1
+25% +$2.29K
OTRK
3930
DELISTED
Ontrak
OTRK
$16K ﹤0.01%
11
+1
+10% +$1.38K
AGRO icon
3931
Adecoagro
AGRO
$1.34B
$16K ﹤0.01%
1,909
AY
3932
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$15.8K ﹤0.01%
600
+200
+50% +$5K
AVXL icon
3933
Anavex Life Sciences
AVXL
$316M
$15.8K ﹤0.01%
6,108
+536
+10% +$1.41K
GDP
3934
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$15.7K ﹤0.01%
1,567
+101
+7% +$982
MPX
3935
DELISTED
Marine Products Corp
MPX
$15.7K ﹤0.01%
1,091
-144
-12% -$2.08K
FLNT
3936
Fluent
FLNT
$129M
$15.7K ﹤0.01%
1,047
+95
+10% +$1.28K
CBAY
3937
DELISTED
Cymabay Therapeutics
CBAY
$15.5K ﹤0.01%
7,933
-2,000
-20% -$7.51K
BLFS icon
3938
BioLife Solutions
BLFS
$1.71B
$15.4K ﹤0.01%
954
+629
+194% +$10.2K
APHA
3939
DELISTED
Aphria Inc. Common Shares
APHA
$15.3K ﹤0.01%
2,929
KALA icon
3940
KALA BIO
KALA
$17.1M
$15.2K ﹤0.01%
2
+1
+100% +$9.66K
SHSP
3941
DELISTED
SharpSpring, Inc.
SHSP
$15.2K ﹤0.01%
1,321
+903
+216% +$9.2K
MRNS
3942
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.1K ﹤0.01%
1,744
-186
-10% -$1.04K
TRP icon
3943
TC Energy
TRP
$66.3B
$15K ﹤0.01%
282
HNRG icon
3944
Hallador Energy
HNRG
$743M
$15K ﹤0.01%
5,041
+2,009
+66% +$6.17K
MCRB icon
3945
Seres Therapeutics
MCRB
$47.4M
$14.9K ﹤0.01%
216
-48
-18% -$3.56K
SAMG icon
3946
Silvercrest Asset Management
SAMG
$78.6M
$14.9K ﹤0.01%
1,181
-203
-15% -$2.56K
KZR
3947
DELISTED
Kezar Life Sciences
KZR
$14.8K ﹤0.01%
370
+152
+70% +$4.68K
GCBC icon
3948
Greene County Bancorp
GCBC
$601M
$14.8K ﹤0.01%
1,026
-2
-0.2% -$28
IRMD icon
3949
iRadimed
IRMD
$1.12B
$14.8K ﹤0.01%
631
-3
-0.5% -$70
PTGX icon
3950
Protagonist Therapeutics
PTGX
$9.84B
$14.7K ﹤0.01%
2,089
+173
+9% +$1.72K

Similar funds

BNP Paribas Financial Markets's Q4 2019 Portfolio in Review

As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.

  • BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
  • BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
  • BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
  • BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
  • BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
  • BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.